Picture of Precision Biosciences logo

DTIL — Precision Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Precision BioSciences Inc reports results for the quarter ended in March - Earnings Summary

* Precision BioSciences Inc  DTIL.OQ  reported a quarterly
adjusted loss of 35 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of $-6.90.  The mean expectation of six analysts
for the quarter was for a loss of $1.91 per share. Wall Street
expected results to range from $-2.60 to -45 cents per share.
    * Revenue rose 100.3% to $17.58 million from a year ago;
analysts
expected $6.02 million. 
    * Precision BioSciences Inc's reported EPS for the quarter
was
$1.70​.
    * The company reported quarterly net income of $8.59
million.
    * Precision BioSciences Inc shares had fallen by 21.5% this
quarter and lost 2.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 25% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Precision
BioSciences Inc is $30.00 
This summary was machine generated from LSEG data May 13 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.91          -0.35          Beat
 Dec. 31 2023      -2.05          -4.06          Missed
 Sep. 30 2023      -4.87          -2.10          Beat
 Jun. 30 2023      -7.32          -3.00          Beat

Recent news on Precision Biosciences

See all news